A T-cell test developed by Adaptive Biotechnologies could become the first commercially available test of its kind, and it may be more effective at detecting past COVID-19 infections than antibody ...
A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer after re-introduction into the body of a cancer patient. This simple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results